These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

698 related items for PubMed ID: 28699533

  • 1. Class A GPCRs: Structure, Function, Modeling and Structure-based Ligand Design.
    Cong X, Topin J, Golebiowski J.
    Curr Pharm Des; 2017 Nov 16; 23(29):4390-4409. PubMed ID: 28699533
    [Abstract] [Full Text] [Related]

  • 2. GPCR structures in drug design, emerging opportunities with new structures.
    Tautermann CS.
    Bioorg Med Chem Lett; 2014 Sep 01; 24(17):4073-9. PubMed ID: 25086683
    [Abstract] [Full Text] [Related]

  • 3. X-ray structure breakthroughs in the GPCR transmembrane region.
    Topiol S, Sabio M.
    Biochem Pharmacol; 2009 Jul 01; 78(1):11-20. PubMed ID: 19447219
    [Abstract] [Full Text] [Related]

  • 4. Structure versus function-The impact of computational methods on the discovery of specific GPCR-ligands.
    Bermudez M, Wolber G.
    Bioorg Med Chem; 2015 Jul 15; 23(14):3907-12. PubMed ID: 25828056
    [Abstract] [Full Text] [Related]

  • 5. Comparing Class A GPCRs to bitter taste receptors: Structural motifs, ligand interactions and agonist-to-antagonist ratios.
    Di Pizio A, Levit A, Slutzki M, Behrens M, Karaman R, Niv MY.
    Methods Cell Biol; 2016 Jul 15; 132():401-27. PubMed ID: 26928553
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Recent Advances in Structure-Based Drug Design Targeting Class A G Protein-Coupled Receptors Utilizing Crystal Structures and Computational Simulations.
    Lee Y, Basith S, Choi S.
    J Med Chem; 2018 Jan 11; 61(1):1-46. PubMed ID: 28657745
    [Abstract] [Full Text] [Related]

  • 12. GPCR Homology Model Generation for Lead Optimization.
    Tautermann CS.
    Methods Mol Biol; 2018 Jan 11; 1705():115-131. PubMed ID: 29188560
    [Abstract] [Full Text] [Related]

  • 13. Improving virtual screening of G protein-coupled receptors via ligand-directed modeling.
    Coudrat T, Simms J, Christopoulos A, Wootten D, Sexton PM.
    PLoS Comput Biol; 2017 Nov 11; 13(11):e1005819. PubMed ID: 29131821
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Current and Future Challenges in GPCR Drug Discovery.
    Topiol S.
    Methods Mol Biol; 2018 Nov 11; 1705():1-21. PubMed ID: 29188556
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Breakthrough in GPCR Crystallography and Its Impact on Computer-Aided Drug Design.
    Ciancetta A, Jacobson KA.
    Methods Mol Biol; 2018 Nov 11; 1705():45-72. PubMed ID: 29188558
    [Abstract] [Full Text] [Related]

  • 18. Applying Structure-Based Drug Design Approaches to Allosteric Modulators of GPCRs.
    Congreve M, Oswald C, Marshall FH.
    Trends Pharmacol Sci; 2017 Sep 11; 38(9):837-847. PubMed ID: 28648526
    [Abstract] [Full Text] [Related]

  • 19. Relevance of rhodopsin studies for GPCR activation.
    Deupi X.
    Biochim Biophys Acta; 2014 May 11; 1837(5):674-82. PubMed ID: 24041646
    [Abstract] [Full Text] [Related]

  • 20. Fitting the complexity of GPCRs modulation into simple hypotheses of ligand design.
    Custodi C, Nuti R, Oprea TI, Macchiarulo A.
    J Mol Graph Model; 2012 Sep 11; 38():70-81. PubMed ID: 23079642
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.